Vasopressin Versus Tranexamic Acid for Control of Blood Loss Related to Abdominal Hysterectomy

PHASE4Not yet recruitingINTERVENTIONAL

Enrollment

387

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

October 1, 2024

Study Completion Date

October 1, 2024

Conditions

Uterine Surgery

Interventions

DRUG

Vasopressin

Hemostatic drug.

DRUG

Tranexamic acid

Hemostatic drug.

OTHER

Saline

Placebo

All Listed Sponsors

lead

Al-Azhar University

OTHER

NCT06290596 - Vasopressin Versus Tranexamic Acid for Control of Blood Loss Related to Abdominal Hysterectomy | Biotech Hunter | Biotech Hunter